Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Favorable efficacy, side effect profile seen with belaperidone in preclinical and clinical studies

Nov. 6, 1998

Phase II trial supports efficacy of pentapeptide antidepressant

Nov. 6, 1998

SB discloses isoquinolyl-benzamide anticonvulsants

Nov. 6, 1998

Reduction in the incidence of dementia obtained with antihypertensive treatment

Nov. 5, 1998

Highly potent H3 receptor antagonist with potential therapeutic use

Nov. 5, 1998

Chinese researchers report that synthetic calcium antagonist improves memory dysfunction

Nov. 5, 1998

Angiotech study of micellar paclitaxel in MS well under way

Nov. 5, 1998

Bayer announces setback in AD drug development

Nov. 5, 1998

New sigma-receptor ligands presented by Sumitomo

Nov. 5, 1998

GlyT-1 technology forms the basis of Allelix and Janssen neuropsychiatric collaboration

Nov. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...